EP1178741A2 - Produit que l'on peut fumer - Google Patents

Produit que l'on peut fumer

Info

Publication number
EP1178741A2
EP1178741A2 EP99911715A EP99911715A EP1178741A2 EP 1178741 A2 EP1178741 A2 EP 1178741A2 EP 99911715 A EP99911715 A EP 99911715A EP 99911715 A EP99911715 A EP 99911715A EP 1178741 A2 EP1178741 A2 EP 1178741A2
Authority
EP
European Patent Office
Prior art keywords
filter
product according
tobacco
smokable product
smokable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99911715A
Other languages
German (de)
English (en)
Inventor
Werner Rahn
Wolfram Röper
Henning Seidel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reemtsma Cigarettenfabriken GmbH
Original Assignee
HF and PhF Reemtsma GmbH and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HF and PhF Reemtsma GmbH and Co filed Critical HF and PhF Reemtsma GmbH and Co
Publication of EP1178741A2 publication Critical patent/EP1178741A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/302—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by natural substances obtained from animals or plants
    • A24B15/303—Plant extracts other than tobacco
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES OF CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
    • A24D3/00—Tobacco smoke filters, e.g. filter tips or filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces of cigars or cigarettes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/308—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances vitamins
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES OF CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
    • A24D3/00—Tobacco smoke filters, e.g. filter tips or filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces of cigars or cigarettes
    • A24D3/06—Use of materials for tobacco smoke filters
    • A24D3/16—Use of materials for tobacco smoke filters of inorganic materials
    • A24D3/163—Carbon
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P70/00—Climate change mitigation technologies in the production process for final industrial or consumer products
    • Y02P70/50—Manufacturing or production processes characterised by the final manufactured product

Definitions

  • the present invention relates to smokable products, such as filter cigarettes, filter cigarillos or filtered cigars, which have a gas-phase-active filter and / or gas-phase-active cigarette paper and / or one or more other components accessible to the mainstream smoke with an addition of gas-phase-active substances and with an additive are provided with antioxidant substances.
  • filter systems with deposits of gas-phase-active substances such as activated carbon are known which specifically reduce the gas phase of cigarillos or cigarettes.
  • Such filter cigarettes are known which specifically reduce the gas phase of cigarillos or cigarettes.
  • CONFIRMATION COPY are described, for example, in DE-PS 41 05 500 Cl or EP-PS 0 558 166 B1.
  • DE-PS 44 16 101 C2 also discloses smokable tobacco products which contain natural antioxidative substances for reducing the mutagenic potential of tobacco smoke.
  • the distribution of blood in the smallest blood vessels - the microcirculation - is the most important part of the blood circulation. This is where the diffusion of oxygen, nutrients and metabolic products between blood and tissue cells takes place.
  • the microcirculation and the macrocirculation in the arteries and veins There are major differences between the microcirculation and the macrocirculation in the arteries and veins: in the smallest blood vessels (capillaries, arterioles and venules), blood cells and blood plasma separate more or less and only reunite in the veins after they have flowed through the microvascular network.
  • the microcirculation is adapted to the requirements of the respective tissue by a series of control mechanisms, its functional state is determined by the flow properties and flow conditions of the blood.
  • the distribution of blood cells in the microvessels is important both for the "nutrition” of adjacent tissue cells (red blood cells) and for the immune response (white blood cells).
  • the functional state of the microcirculation in the oral mucosa - a representative organ region - and other organs or organ regions is temporarily changed.
  • the blood distribution in the microvessels is somewhat restricted, the flow strength in the small blood vessels decreases, and white blood cells appear in the vessels, which temporarily on the Adherent vessel walls (initiation of an immune reaction).
  • HSR main flow smoke
  • NSR secondary flow smoke
  • a smokable product e.g. a filter cigarette, a filter cigarillo or a filtered cigar
  • a) contains a gas phase active filter and / or gas phase active cigarette paper and / or one or more others, the
  • Components accessible to mainstream smoke contain an addition of gas-phase-active substances and b) the strand of tobacco and / or another smokable material and / or other components accessible to the mainstream smoke is / are provided with an addition of substances having an antioxidative effect.
  • components accessible to the mainstream smoke are understood to mean those constituents of smokable products such as cigarettes, cigarillos or cigars which form part or all of the substances which pass into the mainstream smoke when smoked, or other components which elute into the mainstream smoke when smoking become.
  • the invention thus relates to a smokable product which contains a gas-phase-active filter and / or gas-phase-active cigarette paper and whose strand of tobacco and / or another smokable material and / or other components accessible to the mainstream smoke is provided with an additive of substances having an antioxidative effect /are.
  • the product contains either a tobacco rod wrapped in cigarette paper or a tobacco rod wrapped in non-woven paper and cigarette paper, the air permeability of the cigarette paper being 10 to 100 Coresta units (CU), preferably 20 is up to 60 CU, and the air permeability of the nonwoven paper is 4000 to 60,000 CU.
  • the product contains either a tobacco rod wrapped in natural and / or reconstituted tobacco or a tobacco rod wrapped in at least two layers of reconstituted tobacco or film tobacco, the air permeability of one layer of film tobacco being either ⁇ 1 CU ("air impermeable"), or 5 to 100 CU (“air permeable”), preferably 40 to 80 CU.
  • gas-phase active filter is understood to mean a filter which contains 5 to 65% by weight, preferably 20 to 50% by weight, particularly preferably 30% by weight, of a gas-phase-active, porous material of large (inner) Contains surface.
  • the filter has a circumferential filter ventilation zone in the underside and the degree of filter ventilation is 5 to 95%, preferably 25 to 75%.
  • the filter can also contain means for introducing ventilation air into the filter at a different or arbitrary location known to the person skilled in the art.
  • both filter wrapping papers and tipping can be partially or completely zone perforated or naturally porous.
  • the gas phase active filter is a double filter, but it can also e.g. be a mono- or multifilter, the multifilter being any combination of filters from the group consisting of chamber filters, litter filters, monobloc filters and / or core filters.
  • the strand-side part — in the case of the monofilter the whole part — preferably consists of a tissue paper which contains 5 to 65% by weight, preferably 20 to 50% by weight and particularly preferably 30% by weight, of such a surface-rich, gas phase-active material contains.
  • the smokable product is either a filter cigarette with a by a tobacco rod surrounded by cigarette paper or around a filter cigarillo (without cigarette paper) or a filtered cigar, the tobacco rod being surrounded by a cover sheet or a cover and binder made from natural or reconstituted tobacco.
  • a preferred filter - preferably a double filter - has a circumferential filter ventilation zone in the mouth-side part, the tissue paper of the strand-side filter part being a very voluminous paper.
  • the air permeability of the cigarette paper is 10 to 100 Coresta units (CU), preferably 20 to 60 CU, and the degree of filter ventilation is 5 to 95%, preferably 25 to 75%.
  • the tissue paper (in the case of the double filter the tissue paper of the strand-side filter part) preferably contains 30% by weight of a surface-rich material.
  • the strand-side part of the filter is, in particular, a core filter with a core made of tissue paper, which is surrounded by a jacket made of material which is almost impermeable to the mainstream smoke.
  • the gas phase-active filter contains a surface-rich, gas phase-active material which is a porous material with a large (inner) surface from the group consisting of activated carbon, aluminum oxide, aluminum hydroxide, bentonite, cellulose, diatomaceous earth, ion exchangers, light metal salts, sea foam, molecular sieves, Silica gels, clays, and zeolites or combinations thereof, with activated carbon, meerschaum and silica gel being particularly preferred as gas phase-active substances.
  • a surface-rich, gas phase-active material which is a porous material with a large (inner) surface from the group consisting of activated carbon, aluminum oxide, aluminum hydroxide, bentonite, cellulose, diatomaceous earth, ion exchangers, light metal salts, sea foam, molecular sieves, Silica gels, clays, and zeolites or combinations thereof, with activated carbon, meerschaum and silica gel being particularly preferred as gas phase-active substances.
  • filter constructions known per se with gas-phase-active material can be used, for example a litter filter (for example, in the case of a double filter, the line-side filter section is preferably provided with deposits, for example granular, gas-phase-active materials in quantities of 10 to 150 mg), monobloc filter (the gas-phase-active material, preferably activated carbon, is partially bonded in the form of a cylindrical body with, for example, polyolefins), multifilters which contain at least two, possibly different, forms of offering the gas-phase-active material - which may also be different - in addition to the filter phase-retaining filter sections, as well as core Filters in which either the sheath or the core contain or consist of gas-phase-active material, alternatively core filters in which both the sheath and the core contain gas-phase-active but different material or consist of it and other filter constructions of the specified type known to the person skilled in the art.
  • a litter filter for example, in the case of a double filter, the line-side filter section is preferably provided
  • the filters can be channel-ventilated and / or have a mouth-side recess filter section and / or a mouth-side core filter.
  • All of the filter structures mentioned, which contain gas-phase-active material, can even have the antioxidative substances according to the invention both in contain gas-phase-active as well as in the particle-phase-retentive material and additionally be provided with further, admissible additives such as flavors, fragrances, common filter hardeners and other admissible additives for cigarettes and cigarillos.
  • filter structures mentioned which contain gas-phase-active material are also provided with customary filter material which retains the particle phase or additional filter sections which retain the particle phase, in particular with cellulose, cellulose acetate and those described in DE-PS 197 53 193 and DE- PS 197 53 195 and filter materials which retain particle phase and are described in DE-OS 42 05 658.
  • a surface-rich material with a grain size of 2 mm or less, preferably from 15 ⁇ m to 2 mm, or according to a particular embodiment less than 15 ⁇ m, which has an inner specific surface in the area
  • gas-phase-active cigarette paper is understood to mean a cigarette paper which contains at least one of the abovementioned surface-rich, gas-phase-active materials.
  • the cigarette paper can be provided with very fine-grained silica gels, zeolites, aluminum oxides, etc.
  • the gas-phase-active cigarette paper can, for example, be a two-layer tobacco rod wrapper which is provided with finely ground activated carbon in a manner known per se (carbon filled paper innerliner for cigarettes and cigars; Ecusta Paper Division OLIN; Research & Development Dept. report; August 27, 1973).
  • a preferred embodiment of the invention according to the invention is therefore a filter cigarette, the tobacco rod of which has two layers
  • Cigarette paper is wrapped, with the inner layer made of one By-flow smoke-reducing cigarette paper with low air permeability and the outer layer consists of a flavored cigarette paper with an air permeability of 20 to 100 CU, preferably 40 to 80 CU.
  • the antioxidative substances added to the tobacco and / or other smokable materials are preferably selected from the group consisting of ascorbic acid, ⁇ -carotene, retinol, tocopherol (in particular ⁇ -tocopherol), their derivatives (in particular tocopherol acetate) and precursors, eugenol, jasmine aldehyde , Cinnamon, cinnamon extract, (raw) coffee, (raw) coffee extract, caffeic acid methyl ester, caffeic acid ethyl ester, ferulic acid methyl ester, ferulic acid ethyl ester, umbelliferone, scopoletin and curcumin, the substances being selected either individually or in combination can be added together to the tobacco.
  • the additive contains or comprises ⁇ -tocopherol, tocopherol acetate (ToAc) and / or tocopherol succinate.
  • the tobacco rod is added with more than 0.1% by weight to 5% by weight (based on the amount of tobacco), preferably more than 0.5% by weight to 4% by weight and particularly preferably 1 % By weight to 2.5% by weight of antioxidant substances. If the additive comprises more than one antioxidative substance, the amount added to the tobacco is in each case at least 0.25% by weight to 1.25% by weight according to a particular embodiment of the invention.
  • - depletion of the gas phase with simultaneous enrichment of the particle phase can be added to the components of the smokable products which are accessible to the mainstream smoke, but also also the surface-rich, gas-phase-active materials mentioned.
  • this addition of gas-phase-active substances can optionally be carried out with a gas-phase-active filter and / or gas-phase-active cigarette paper can be combined or replace the gas-phase-active filter and / or the gas-phase-active cigarette paper.
  • the filter cigarette of the present invention has a tobacco rod surrounded by cigarette paper.
  • other smokable materials including mixtures of these other materials containing tobacco, can also be used in the products according to the invention.
  • “Kretek” cigarettes with the addition of up to 50% by weight of smokable spices or pure, tobacco-free plant cigarettes are also included.
  • tobacco in the following, reference is made exclusively to "tobacco", but this term is always intended to include the other smokable materials mentioned.
  • the tobacco or tobacco mixtures used consist either entirely or predominantly of expanded or unexpanded La ina tobacco, but can also contain so-called technical tobacco such as rib cut or foil tobacco (FT).
  • FT rib cut or foil tobacco
  • the antioxidative substances according to the invention are advantageously incorporated directly into the film tobacco in a manner known to those skilled in the art.
  • the amounts of 0.1 to 10%, preferably 1% to 7% and particularly preferably 2% to 4 of the film tobacco are used % incorporated.
  • Such film tobacco is particularly suitable for use in cigarillos and cigars, for example as cover and / or binder, but can also be used directly as (smokable) tobacco or added to the tobacco mixtures for cigarillos, cigars or cigarettes in the form of coarse or fine cuts become.
  • tobacco mixtures for cigarettes can be used:
  • mixtures can also contain technical tobacco (ribs, FT), where the respective lamina (leaf tobacco) portions can be wholly or partially expanded.
  • ribs, FT technical tobacco
  • lamina lamina
  • smoke products according to the invention to be produced therefrom contain the claimed antioxidative substances.
  • AB mixtures are often used, e.g. according to the following mixture recipe range preferred according to the invention:
  • Positioning of the product can result in deviations or other tobacco blends from “light” to “dark” can be used.
  • the antioxidative substances can not only be added to the tobacco, but also incorporated into individual components of the tobacco products that are accessible to the mainstream smoke, such as filters, wrapping papers, wrapping tobacco, carrier substances, seam glue, etc., in a manner known per se. If the antioxidative substances are incorporated in the cigarette paper or in the glue of the cigarette seam, the preferred amounts are more than 0.1% by weight to 20% by weight, with amounts of 1 to 7.5% by weight being particularly preferred are preferred.
  • the tobacco rod can also be provided in a manner known per se with further additions of auxiliaries, fillers and flavorings (additives).
  • the tobacco rod When adding large amounts of antioxidant substances to the tobacco mixture, especially when adding tocopherol acetate, it has proven to be advantageous to provide the tobacco rod with a double-layer cigarette rod wrapper (non-woven paper), the inner layer made of highly porous wrapping paper with an air permeability of 4000 to 60 000 CU consists and the outer layer of cigarette paper, which is customary per se.
  • smaller amounts of the antioxidative substances added according to the invention according to DE-PS 42 44 467 can also be applied in encapsulated form to the inner, highly porous wrapping paper.
  • multi-layer tobacco rod wrapping combinations can also be used.
  • special ciga Rescue papers for a wide variety of purposes known to those skilled in the art can be combined or used with the internal, highly porous wrapping paper, such as flavored papers (for example according to EP 0 294 972), sidestream smoke reducing papers (for example according to EP 0 251 254 or EP 0 338) 156) or papers for self-extinguishing cigarettes (for example according to EP 0 375 844).
  • these cigarette papers especially when using smaller amounts of substances having an antioxidative effect on the smoking article according to the invention - can also be used on their own, ie in one layer. This possibility also exists with foil tobacco wrappings, especially with cigarillos.
  • Combinations of preferred tobacco rod wrapping combinations according to the invention are shown in Table 1.
  • the first (upper) block relates to the filtered cigarillos or cigars according to the invention
  • the second (lower) block relates to the filter cigarettes according to the invention.
  • the wrappings listed can be meaningfully interchanged or combined with one another (within a line) or with one another (different lines).
  • a filter cigarillo e.g. an approximately cigarette-shaped filter cigarillo, which is provided with a sheet of air-permeable or air-impermeable film tobacco and a cover sheet of natural tobacco and has a chamber filter, the central chamber of which is filled with activated carbon.
  • the filter used is a gas-phase-active filter according to PCT / EP97 / 06390, which is a filter containing activated carbon, the filter cigarette produced with this filter
  • (a) contains a tobacco rod surrounded by a cigarette paper with an air permeability of 20 to 100 CU or a tobacco rod covered by a cigarette paper with an air permeability of 20 to 100 CU, and
  • b) contains a double filter with a degree of filter ventilation of 5 to 95%, the strand-side part of which consists of a very voluminous tissue paper containing 5 to 65% by weight, preferably 20 to 50% by weight, microfine ground activated carbon, in the mouth-side part is provided with a filter ventilation zone running in the circumferential direction.
  • the above-mentioned substances are preferably added to the tobacco rod either individually or in combination with one another.
  • these substances can also be used in addition to other components of the invention tobacco products according to the invention are added, of which preferably the mouth-side filter part.
  • the tissue paper used in the strand-side filter element has a basis weight of approximately 40 to 60 g / m 2 , an activated carbon content of 5 to 65% and a thickness of 150 to 200 ⁇ m.
  • a preferred variant has a weight per unit area of 50 g / m 2 and an activated carbon content of 30% by weight with a thickness of 180 ⁇ m.
  • the strand-side filter part of the double filter is a core filter according to DE 42 05 658 C2, in which the core is made of carbon-containing tissue paper as in the first-mentioned embodiment, which is surrounded by a jacket made of material which is almost impermeable to the mainstream smoke .
  • This almost smoke-impermeable material consists, for example, of highly compressed cellulose acetate fibers.
  • the filter cigarette according to the invention has the advantage over conventional filter cigarettes of comparable strength that the microcirculation, in particular of the oral mucosa, is significantly less impaired when a gas-phase-active filter is used and additional antioxidative substances are added to the tobacco rod, thus preventing undersupply of the tissue becomes. This positive effect is significantly enhanced especially when ⁇ -tocopherol or tocopherol acetate is added.
  • the proportion of pollutants in the gas phase can be reduced by using a gas phase-active filter without the taste according to the invention being adversely affected, that is to say the taste of the main stream smoke is adversely affected.
  • the sidestream smoke likewise has no negative, ie unpleasant, odor changes.
  • the smokable product is a filter cigarette which contains a tobacco rod covered with a cigarette paper with an air permeability of 40 to 60 CU, the nonwoven paper being a highly porous nonwoven paper with an air permeability of 32,000 CU, and the filter of which is a double filter is, the strand-side part of a very voluminous, 30 wt .-%, microfine ground activated carbon-containing tissue paper, which is provided with a circumferential filter ventilation zone, which consists of cellulose acetate in the mouth-side part, the tobacco rod with a Addition of about 2% tocopherol acetate is provided.
  • the double filter has a degree of filter ventilation of about 20 to about 25%, about 50% or about 60 to 75%.
  • the product Properties of these preferred cigarettes are shown in Table 2 below.
  • the principle according to the invention - enrichment of the gas phase, for example by using a gas-phase-active filter and / or by using gas-phase-active cigarette paper, with simultaneous enrichment of the particle phase by exposure to substances having an antioxidative effect - also by using tobacco cartridges (so-called Plug-in cigarettes) can be realized, ie by providing a fleece-wrapped tobacco rod and a sleeve with a gas-phase-active filter that the consumer puts together for the finished smoke product (eg cigarette).
  • the addition of antioxidant substances can accordingly take place on the tobacco itself and / or, for example, on the cigarette paper of the sleeve.
  • the present invention therefore also relates to the use of a nonwoven-coated strand of tobacco and / or another smokable material and a filter sleeve which comprises a gas-phase-active filter, for the production of a smokable product according to the invention, the strand of tobacco and / or another smokable material and / or other components accessible to the mainstream smoke being provided with an additive of substances having an antioxidative effect.
  • the present invention also relates to the analogous use of so-called (unfiltered) "plug-in cigarillos" in connection with a filter sleeve which comprises a gas phase active filter for producing a smokable product according to the invention.
  • the present invention therefore also relates to the use of a strand of tobacco and / or another smokable material, which is coated with natural and / or reconstituted tobacco, and a filter sleeve, which comprises a gas phase active filter, for producing a smokable product, whereby the strand of tobacco and / or another smokable material and / or the wrapper of tobacco and / or other components accessible to the mainstream smoke is / are provided with an additive of substances having an antioxidative effect.
  • the strand of tobacco and / or another smokable material can alternatively be wrapped with at least two layers of reconstituted tobacco or film tobacco.
  • the casing can be both airtight ( ⁇ 1 CU) and airtight (with an air permeability of 5 to 100 CU, preferably 40 to 80 CU) or consist of a combination of airtight envelope tobacco and air-permeable envelope tobacco.
  • the tocopherol acetate (ToAc) was applied to the cut tobacco in the form of a 20% ethanol solution.
  • the procedure was such that in each case 10 kg of the tobacco were sprayed with the ToAc solution in a rotating treatment drum in the manner known to the person skilled in the art.
  • a dosage of 1.5% ToAc in the tobacco was aimed for.
  • the solvent was then at 22 ° C and 63% rel. Air is vented, at the same time conditioning for cigarette production took place (cigarette versions 1 C and 1 D).
  • the untreated tobacco mixture (cigarette versions 1 A and 1 B) served as a comparison.
  • the cigarettes were manufactured with two different filters.
  • the gas phase active filters were double filters, the part of the strand side of which consists of a carbon-containing tissue paper (with 30% by weight of microfine ground activated carbon) and the part of the mouth made of cellulose acetate fibers. These filters were referred to in the description as activated carbon filters (AF) and are found in cigarette versions 1 B and 1 C. These conventional cigarette filters were made from cellulose acetate fibers (CA) (cigarette versions 1 A and 1 D). Tab. 3
  • the cigarettes were smoked according to DIN 10240, the main flow smoke condensate (HSR) being obtained electrostatically.
  • the particle phase of the so-called secondary flow (NSR) was also isolated.
  • 10 test cigarettes were smoked in an 18 m room, lined with V2A steel, so that only the NSR could be distributed in the room.
  • An aliquot of 180 l was then passed through a teflon filter at a flow rate of 3 l / min to separate the particle phase.
  • the stubs unused tobacco residues
  • the smoked cigarette filters were separated and collected after the cigarettes had been consumed.
  • HSR, NSR, Stummel and the smoked filters were used to produce ethanolic solutions and extracts for analysis on ToAc.
  • the ToAc was quantified using HPLC with DAD (High Performance Liquid Chromatography with Diode Array Detector).
  • a Purospher RP 18, 5 ⁇ m, No548l63 column was used.
  • Methanol was used as the eluent at a flow rate of 1.0 ml / min and a temperature of 35 ° C. The detection took place at 285 nm.
  • Tab. 4 lists the amounts of HSR condensate (mg / cigarette) and the amounts of ToAc (mg / cigarette) in the HSR condensate for the cigarette variants containing ToAc. 4 is the rel. Share (%) of ToAc in the HSR. The results obtained show that the proportion of ToAc in the HSR condensate (%) for the cigarettes with cellulose acetate filters and carbon filters is at a comparable level, namely on average around 12%.
  • Tab. 5 gives an overview of the distribution of the ToAc during smoking or the accounting after the smoking process has been completed. In the second column of Tab. 5 you can find the amounts of ToAc (mg / cigarette) that were present at the start of smoking. This arithmetically results from the amount of tobacco per cigarette and the amount of ToAc added to the tobacco.
  • Tab. 5 shows the recovered amounts ToAc (mg / cig.) In HSR, NSR, filter and stub, as well as the resulting sum and the recovered amount (%), based on the amount presented before smoking .
  • Example 1 The following 4 test objects were examined as examples. All test objects were allied for the trial, i.e. it was neither recognizable for the test subjects nor for the investigator which cigarette was smoked. These were cigarettes from the filling flavor segment with the following names in accordance with Example 1:
  • GCP Good Clinical Practice
  • Age 38 to 43 years (mean 40.5 years)
  • Body mass 73 to 78 kg (mean 75.3 kg)
  • Body length 172 to 176 cm (mean 174.1 cm)
  • Allergic diathesis Intolerance or hypersensitivity of any kind; Diabetes melutus; Hyperuricaemia; Hyperthyroidism or other endocrine diseases; chronic or terminal illnesses (carcinoma, tuberculosis); Hypertension; Heart failure, coronary insufficiency; coronary artery disease; Heart valve defects; Myocardial infarction; Stroke; cerebral circulatory disorders TIA (transient ischemic attack; stage Ila of cerebral circulatory disorder); chronic obstructive pulmonary disease COLD; surgery on the intestine; any other chronic illness; Hemodialysis; just a fully functional kidney; Prostate hyperplasia; Blood clotting disorders. Expressed intention to quit smoking.
  • Chronic liver disease (elevation of transaminases to twice the normal values); Kidney disease or renal dysfunction (increase in serum creatinine> 1.2 mg% (1.5 mg%) or creatinine clearance 50 - 80 ml / min ( ⁇ 50 ml / min); white blood cell count below 3500 / ⁇ l; platelet count below 100,000 / ⁇ l.
  • Suspected intestinal dysfunction suspected pulmonary or bronchial diseases (exception: mild chronic bronchitis). In need of stomatological restoration; lack of more than 2 teeth; periodontal disease, gingivitis.
  • Subjects 12 hours before the examination appointments no alcohol, no coffee, tea or Coca-Cola ®. At least 6 hours of sleep a day; sufficient acclimatization and rest before the measurements (blood pressure RR (measured with Riva-Rocci apparatus) normal, heart rate normal, respiratory rate normal).
  • blood pressure RR measured with Riva-Rocci apparatus
  • Double blind study determination of the examination procedure by a random generator.
  • Boundary conditions of the investigations constant (temperature regulation, macro circulation, acclimatization time approx. 2 hours).
  • an intravital microscopic examination unit is used in the combined incident-transmitted light procedure with selective light generators and selective filtering.
  • the primary images obtained are processed and processed with computer assistance (secondary image processing and processing with the KONTRON computer system).
  • the vital microscopic findings are made under defined lighting and filter conditions; these relate to: spectral distribution of the reflected light and transmitted light components, beam characteristics, angle of incidence of the rearing component, specific filtering of the reflected and penetrating components, emission and absorption spectra of the various structures in the target tissue.
  • Microphotographic snapshots in 35mm, roll film or plate format (NIKON, LINHOF with ARRI adapter; up to 1/8000 sec); Film material up to ISO 3200/36 °).
  • 35mm cine film (color or black and white), complete camera and control system ARRI (up to 120 frames / sec), Agfa special film; automatic Agfa film processing system.
  • Video recordings (U-matic, Super-VHS; JVC, PANASONIC, BLAUPUNKT, SIEMENS).
  • FIG. 1 shows the structure of the intravital microscopic examination unit based on a block diagram.
  • a BAXTER angioscope (special coronaroscope) is placed in a commercially available sterile O.P. - Swab placed so that buccal fixation of the optical apparatus is guaranteed and at the same time the subject is stressed in a reasonable manner.
  • This procedure is simulated with the test subjects before the start of the study and is accepted by all test persons.
  • Fig. 2 shows a schematic representation of the placement of the distal optical apparatus in the cavu oris of the test subjects.
  • test subjects At the request of the test subjects, an informal fixation of the head by an ophthalmological attachment (jaw rest, forehead rest) is carried out during exposure to the test objects - individually adjusted in a sitting position.
  • the test subjects When applying the test objects, the test subjects are not prescribed defined exposure conditions; they can proceed in the manner of their habits (train volume, train frequency, number of trains per test object, time).
  • This characteristic denotes the number of adherent white blood cells n that adhere to a defined venal inner wall surface A for more than 5 seconds.
  • This characteristic describes the flow (current) of the red blood cells, i.e. the particle flow.
  • the measured values are computer-aided in secondary image processing (KONTRON system). Geometric dimensions within a microvessel (diameter d, radius r) are measured in the normal to the longitudinal axis of the inner endothelial surface to the opposite endothelial inner surface (tangents). This is shown schematically in FIG. 3.
  • the initial values are compared with the measured values at the measurement times of 2 minutes to 12 minutes. Furthermore, it is checked whether significantly different characteristic changes occur after exposure of different test objects (comparison of the measured values after exposure of different test objects at the same measurement times).
  • test subject After the diagnosis has been made, the test subject is asked for a medical follow-up consultation.
  • the follow-up discussion serves the further holidays. establishing the relationship of trust and preparing for the next examination date.
  • test person is also asked about the test object of the exposure, in order to find out whether may have falsified redundant psychological or vegetative-somatic factors of the measurement result due to individual aversion to a specific test object. No evidence of such falsifications was obtained in the context of the present study.
  • FIG. 4 shows an example of the number of blood cell-perfused nodes (nNP) as a function of the time for the cigarette versions 1 A to 1 D according to Example 1.
  • microperfusion is determined based on the number of blood cell perfused nodes - in conventional filter cigarettes (1 A) is much more impaired than in the case of gas phase active filters (1 B).
  • exposure to tocopherol acetate (1 D) compared to conventional filter cigarettes also reduces the impairment of the microcirculation to a comparable extent.
  • filter cigarettes according to the invention which are distinguished by the combination of a gas-phase-active filter with a tobacco rod (1 C) to which antioxidant substances (here tocopherol acetate) are applied (1 C), there is a further significant mitigation of smoking effects on microcirculation. A few minutes after the end of the exposure, the number of blood cell perfused nodes again increases to the initial value before the exposure.
  • Example 1 Full-flavor cigarettes, described in Example 1 as version 1A, were used as a comparison to evaluate the active substances cureumin and ferulic acid ethyl ester with regard to their transitions into the HSR and their physiological action, described in Example 5.
  • the procedure was such that 100 g of cut tobacco, as contained in the 1 A cigarettes, were charged with the ethanoic solutions of cureumin or ethyl ferulate.
  • Evaporation of the alcohol was handmade with the tobacco Manufactured cigarettes that corresponded to those of the comparison 1 A in terms of their equipment. The three versions of cigarettes were smoked as described in Example 2.
  • the treated tobaccos and the condensates of the HSR were then used for analyzes of cureumin or ferulic acid ethyl ester.
  • the analyzes were carried out by means of HPLC as described in Example 2. However, a mixture of water, tetrahydrofuran, acetonitrile and acetic acid was used as the eluent, specifically for cureumin in a ratio of 55/25/20/1 and for ethyl ferulate in a ratio of 77/13/9/1.
  • a Purospher C18 column was used, the detector was set to 420 nm for cureumin and 325 nm for ethyl ferulate.
  • Table 6 shows the concentration of active ingredient (%) that the treated tobacco had and the percentage that was found in the HSR condensate.
  • Example 4 The effect of the filter cigarettes produced according to Example 4 on the microcirculation of the oral mucosa of 8 subjects was compared with that in Example 3 (Sections A.2 to D. [methodical Part]) described intravital microscopic test methods examined in a double-bundle experiment.
  • FIG. 6 shows an example of the number of adherent white blood cells nWBC / A as a function of the time for the filling flavor cigarettes (according to Example 4) with and without the additives cureumin or ethyl ferulate (versions 1A, B 143 and B 142).
  • Example 1 An American blend mixture was charged with 2% by weight of tocopherol acetate (based on the amount of tobacco), and the corresponding test and comparative cigarettes were produced as in Example 1.
  • Fig. 1 Block diagram of the intravital microscopic examination unit.
  • Fig. 2 Schematic representation of the placement of the distal optical apparatus in the cavum oris of the test subjects.
  • O.P. -Tab In a sterile O.P. -Tab is the fiber optic cable embedded, so that a reasonable fixation between the rack of the right lower jaw and cheek inside is guaranteed.
  • Fig. 4 Measurement of the number of blood cell-perfusing nodes as a function of the time after the start of exposure in the investigation of conventional and inventive filter cigarettes.
  • Fig. 5 Measurement of the number of adherent white blood cells as a function of the time after the start of exposure when examining conventional and inventive filter cigarettes.
  • Fig. 6 Measurement of the number of adherent white blood cells as a function of the time after the start of exposure in tests for filling flavor cigarettes with and without additives.

Landscapes

  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Cigarettes, Filters, And Manufacturing Of Filters (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Cette invention concerne des produits que l'on peut fumer, tels que des cigarettes avec filtre, des cigarillos avec filtre ou des cigares pourvus d'un filtre. Ces produits contiennent des substances actives antioxydantes supplémentaires et possèdent un filtre actif vis-à-vis de la phase gazeuse et/ou du papier à cigarettes actif vis-à-vis de la phase gazeuse et/ou un ou plusieurs autres composants laissant passer le flux principal de fumée et contenant des substances actives vis-à-vis de la phase gazeuse supplémentaires.
EP99911715A 1999-02-26 1999-02-26 Produit que l'on peut fumer Withdrawn EP1178741A2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1999/001263 WO2000049901A2 (fr) 1999-02-26 1999-02-26 Produit que l'on peut fumer

Publications (1)

Publication Number Publication Date
EP1178741A2 true EP1178741A2 (fr) 2002-02-13

Family

ID=8167226

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99911715A Withdrawn EP1178741A2 (fr) 1999-02-26 1999-02-26 Produit que l'on peut fumer

Country Status (19)

Country Link
EP (1) EP1178741A2 (fr)
JP (1) JP2003500008A (fr)
KR (1) KR20010108248A (fr)
AU (1) AU3030799A (fr)
BG (1) BG105844A (fr)
CA (1) CA2360852A1 (fr)
CZ (1) CZ20012899A3 (fr)
EA (1) EA200100917A1 (fr)
EE (1) EE200100445A (fr)
HR (1) HRP20010596A2 (fr)
HU (1) HUP0203227A3 (fr)
IL (1) IL144252A0 (fr)
IS (1) IS6059A (fr)
NO (1) NO20014133L (fr)
PL (1) PL353568A1 (fr)
SK (1) SK12032001A3 (fr)
TR (1) TR200102488T2 (fr)
TW (1) TW480157B (fr)
WO (1) WO2000049901A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100381082C (zh) * 2003-03-14 2008-04-16 韩力 一种非可燃性电子雾化香烟
CN100381083C (zh) * 2003-04-29 2008-04-16 韩力 一种非可燃性电子喷雾香烟
CN2719043Y (zh) 2004-04-14 2005-08-24 韩力 雾化电子烟
DE102005005175A1 (de) 2005-02-01 2006-08-10 Reemtsma Cigarettenfabriken Gmbh Filtercigarette
JP2008543537A (ja) * 2005-06-14 2008-12-04 エクスノックス テクノロジーズ リミテッド 毒素及び環境汚染物質の捕捉
KR100676149B1 (ko) * 2005-06-24 2007-02-01 한현수 흡연 여과용 촉매 여과물질, 이를 포함하는 담배필터, 담배및 끽연용구
CN201067079Y (zh) 2006-05-16 2008-06-04 韩力 仿真气溶胶吸入器
RU2328191C1 (ru) * 2006-12-12 2008-07-10 Олег Иванович Квасенков Способ получения легкого кретека
CN201379072Y (zh) 2009-02-11 2010-01-13 韩力 一种改进的雾化电子烟
US8903228B2 (en) 2011-03-09 2014-12-02 Chong Corporation Vapor delivery devices and methods
MX356624B (es) 2011-03-09 2018-06-06 Chong Corp Sistema de entrega de medicamento.
US9399110B2 (en) 2011-03-09 2016-07-26 Chong Corporation Medicant delivery system
EP2606751A1 (fr) * 2011-12-21 2013-06-26 Reemtsma Cigarettenfabriken GmbH Article contenant du tabac
CN103099307A (zh) * 2012-11-13 2013-05-15 苏州谷力生物科技有限公司 一种添加活性炭薄片卷烟的制备方法
US20190192449A1 (en) * 2016-08-31 2019-06-27 Richard Baybutt Composition and use thereof
KR102450712B1 (ko) * 2019-12-16 2022-10-04 주식회사 케이티앤지 소리가 발생되는 흡연 물품
KR102450713B1 (ko) * 2019-12-16 2022-10-04 주식회사 케이티앤지 소리가 발생되는 흡연 물품

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE416101C (de) 1923-04-09 1925-07-09 Octave Harmel Maschine zum Spalten von Holz, insbesondere Brennholz
US4805644A (en) 1986-06-30 1989-02-21 Kimberly-Clark Corporation Sidestream reducing cigarette paper
US4804002A (en) 1987-05-29 1989-02-14 P. H. Glatfelter Company Tobacco product containing side stream smoke flavorant
US4915118A (en) 1988-04-20 1990-04-10 P. H. Glatfelter Company Smoking article wrapper and method of making same
DE3840329A1 (de) 1988-11-30 1990-06-07 Glatz Julius Gmbh Umhuellung fuer raucherartikel
US5365951A (en) * 1990-08-24 1994-11-22 Philip Morris Incorporated Concentric smoking filter having cellulose acetate tow periphery and carbon-particle-loaded web filter core
DE4105500C1 (fr) 1991-02-19 1992-06-17 H.F. & Ph.F. Reemtsma Gmbh & Co, 2000 Hamburg, De
DE4205658A1 (de) 1992-02-25 1993-08-26 Reemtsma H F & Ph Ventilierte filtercigarette
DE4244467C2 (de) 1992-12-24 1996-11-14 Reemtsma H F & Ph Cigarette
US5404890A (en) * 1993-06-11 1995-04-11 R. J. Reynolds Tobacco Company Cigarette filter
DE4416101C2 (de) * 1994-04-19 1997-06-12 Reemtsma H F & Ph Tabakerzeugnisse oder Tabakerzeugnissen ähnliche Waren mit antioxidativ wirkenden Naturstoffen und Verfahren zur Herstellung derselben
DE19753195A1 (de) 1997-11-21 1999-05-27 Reemtsma H F & Ph Biologisch abbaubarer Filter für Cigaretten
DE19753193A1 (de) 1997-11-21 1999-05-27 Reemtsma H F & Ph Biologisch abbaubarer Filter für Cigaretten

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0049901A2 *

Also Published As

Publication number Publication date
KR20010108248A (ko) 2001-12-07
AU3030799A (en) 2000-09-14
JP2003500008A (ja) 2003-01-07
WO2000049901A3 (fr) 2002-07-11
SK12032001A3 (sk) 2002-01-07
HUP0203227A2 (hu) 2003-01-28
EE200100445A (et) 2002-12-16
EA200100917A1 (ru) 2002-08-29
CA2360852A1 (fr) 2000-08-31
IS6059A (is) 2000-08-27
NO20014133D0 (no) 2001-08-24
IL144252A0 (en) 2002-05-23
BG105844A (bg) 2002-04-30
HUP0203227A3 (en) 2003-02-28
PL353568A1 (en) 2003-12-01
CZ20012899A3 (cs) 2002-07-17
NO20014133L (no) 2001-10-22
WO2000049901A2 (fr) 2000-08-31
TR200102488T2 (tr) 2002-11-21
HRP20010596A2 (en) 2002-08-31
TW480157B (en) 2002-03-21

Similar Documents

Publication Publication Date Title
EP1178741A2 (fr) Produit que l'on peut fumer
EP0756461B1 (fr) Produits du tabac ou substances analogues contenant des substances naturelles a action antioxydante, et leur procede de production
DE2939965C2 (fr)
DE69012823T2 (de) Hilfsmittel zum einstellen des rauchens oder zur verwendung in nichtrauchergebieten.
DE69325329T2 (de) Zigarettenfilter für inhalatorische Anwendung von Taurin
DE69411288T2 (de) Konzentrischer Rauchfilter mit einem Aussenmantel aus einem Zelluloseazetatstrang und mit einem Kern aus einer Aktivkohle enthaltenden Filterbahn
DE3854281T2 (de) Filter für Tabakrauch.
DE3228950C2 (fr)
CH658594A5 (de) Arzneipraeparat mit antinikotinwirkung und verfahren fuer seine herstellung.
DE602005005088T2 (de) Rauchlose zigarette
Hollister Tetrahydrocannabinol isomers and homologues: contrasted effects of smoking
WO2006081931A1 (fr) Cigarette filtre
DE19703003A1 (de) Cigarette mit reduzierter Fleckenbildung und vermindertem Nebenstromrauch
AT501560A1 (de) Verwendung von kräuterzigaretten
LV11519B (en) Ventilated filter cigarette
DE3201101A1 (de) Zigarettenfilterstab
DE3688617T2 (de) Verfahren zur Beimischung einer festen teilchenförmigen Komponente in Aerosolpräparate zur Inhalation des Nikotins.
US6935347B2 (en) Smoking artifact
DE69202392T2 (de) Verbesserungen betreffend Rauchartikel.
EP0450253B1 (fr) Moyen pour se désaccoutumer du tabac
Borbely Die Beeinflussung des Schlafs durch Hypnotika
DE102014007505A1 (de) Nahrungs-und/oder Genussmittel vorzugsweise zur Raucherentwöhnung
DE69402241T2 (de) Verwendung von 2-Acetylpyridine zur Herstellung eines Arzneimittles zur Unterdrückung des Rauchens
DE4208211C2 (de) Verwendung einer Zusammensetzung mit Menthol für einen Nikotinentzug
KR100304732B1 (ko) 무공해 무독성 들깻잎담배의 제조방법

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010925

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 20010925;LT PAYMENT 20010925;LV PAYMENT 20010925;MK PAYMENT 20010925;RO PAYMENT 20010925;SI PAYMENT 20010925

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: REEMTSMA CIGARETTENFABRIKEN GMBH

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030207